Prediabetes at 6.4% HbA1c signals urgent need for early intervention to prevent cardiovascular disease

Emerging research underscores that an HbA1c of 6.4% is a critical warning sign for future vascular problems, prompting a shift in clinical focus toward early action and comprehensive risk management beyond glucose levels.

An HbA1c result of 6.4% should be read less as a near-miss and more as an early warning. In the American Diabetes Association’s 2025 Standards of Care, an A1c of 5.7% to 6.4% sits in the prediabetes range, while 6.5% and above meets the diagnostic threshold for diabetes. The same guidance says prediabetes is an intermediate state between normal glucose control and diabetes, and that it is linked not only to later diabetes but also to cardiovascular disease and other cardiometabolic problems. It adds that finding prediabetes should prompt a wider check for cardiovascular risk factors. (diabetesjournals.org)

That matters because risk does not suddenly appear only when a person crosses the 6.5% line. A CDC-backed systematic review found that diabetes incidence rises sharply across the A1c spectrum from 5.0% to 6.5%. People in the 6.0% to 6.5% band had a 25% to 50% chance of developing diabetes over five years, compared with 9% to 25% for those in the 5.5% to 6.0% range and less than 9% for those between 5.0% and 5.5%. The ADA also cautions that A1c is not the best diagnostic tool in every situation, including pregnancy, some haemoglobin disorders, haemodialysis, recent blood loss or transfusion, haemolysis and erythropoietin therapy, where plasma glucose criteria are preferred. (stacks.cdc.gov)

The cardiovascular signal is not trivial. A 2020 BMJ meta-analysis pooled 129 studies covering 10,069,955 people and found that, in the general population, prediabetes was associated with a 13% higher risk of death from any cause, a 15% higher risk of composite cardiovascular disease, a 16% higher risk of coronary heart disease and a 14% higher risk of stroke over a median follow-up of 9.8 years. The paper also found elevated risks among patients who already had atherosclerotic cardiovascular disease, suggesting that glucose levels below the diabetes threshold are not benign even in people who are already medically vulnerable. (bmj.com)

Newer real-world data point in the same direction. Kaiser Permanente researchers reported in March 2026 that a study of more than 1.3 million adults aged 18 to 90, none of whom had previously been diagnosed with diabetes or heart disease, found a clear gap between normal HbA1c readings and prediabetes. Over five years, the cohort recorded 28,615 atherosclerotic cardiovascular disease events; 20,664 of them occurred in the prediabetes group and 7,951 in the normal-blood-sugar group. Overall, adults with prediabetes had a 21% higher risk of cardiovascular disease than those with HbA1c below 5.7%. (divisionofresearch.kaiserpermanente.org)

The same Kaiser report suggests the hazard may be especially important earlier in adult life. Among people aged 18 to 34, prediabetes was linked to a 54% higher cardiovascular risk; among those aged 35 to 44, the increase was 26%. Obesity compounded the problem: about 31% of the study population had obesity, and the researchers found a 32% increased cardiovascular risk in adults with both obesity and prediabetes, compared with 22% for prediabetes alone and 10% for obesity alone. Jamal S. Rana, the study’s lead author, said: “Our study adds to the evidence that in people with prediabetes, physiological changes are already underway that increase risk for cardiovascular disease.” (divisionofresearch.kaiserpermanente.org)

For patients, the message from heart specialists is not panic but urgency. The American Heart Association says prediabetes means blood sugar is above normal but not yet in type 2 diabetes territory, and describes it as “a warning sign and a chance to take action early”. Its June 2026 patient guidance says people with prediabetes are more likely to develop type 2 diabetes and are also at higher risk of heart attack and stroke. It points to healthier eating, greater physical activity and reaching or maintaining a healthy weight as the strongest tools, while also highlighting smoking cessation, stress management and adequate sleep. The group says some people can reverse prediabetes and avoid or delay type 2 diabetes. (heart.org)

There is also evidence that improvement at this stage can pay off well beyond glucose numbers. Harvard Health highlighted research published in Lancet Diabetes & Endocrinology on 12 December 2025 that followed more than 2,900 people with prediabetes for 20 years in the United States and 30 years in China. In that work, remission meant returning blood sugar to normal, such as fasting glucose below 100 mg/dL or HbA1c below 5.7%. People who achieved that through diet, exercise or both cut their risk of death from heart disease by about 50%, while rates of heart attacks, strokes and related problems were 32% lower than in those whose blood sugar stayed elevated. (health.harvard.edu)

Taken together, those findings argue against treating 6.4% as a reassuringly “almost normal” result. It is not diabetes, but it is close enough to the threshold, and sufficiently associated with future vascular and metabolic harm, that clinicians have reason to monitor it, reassess it regularly and look beyond glucose alone to blood pressure, lipids, body fat distribution and other risk markers. The ADA says people with prediabetes should be tested yearly, and both heart and diabetes guidance present this stage as an opportunity to act before more permanent disease takes hold. (diabetesjournals.org)